Intended for healthcare professionals

News

Depression: EU approves expanded use of esketamine for rapid reduction of symptoms

BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n398 (Published 10 February 2021) Cite this as: BMJ 2021;372:n398